|
2BR9
14-3-3 Protein Epsilon (Human) Complexed to Peptide
Deposited 2005-05-03
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–233(233 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;40% MPD, 5% PEG10000, 0.1M CACODYLATE PH6.5. PROTEIN IN 150MM NACL, 50MM TRIS PH8, pH 8.00
|
Resolution 1.75 Å
R-free 0.239
|
|
3UAL
Crystal Structure of 14-3-3 epsilon with Mlf1 peptide
Deposited 2011-10-21
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–232(232 aa)
Fragment:UNP residues 1-232
|
Not recorded
|
TBU TERTIARY-BUTYL ALCOHOL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;277 K;0.1 M Na-Citrate, 35% tert-butanol, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.222
|
|
3UAL
Crystal Structure of 14-3-3 epsilon with Mlf1 peptide
Deposited 2011-10-21
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–232(232 aa)
Fragment:UNP residues 1-232
|
Not recorded
|
TBU TERTIARY-BUTYL ALCOHOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;277 K;0.1 M Na-Citrate, 35% tert-butanol, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.222
|
|
6EIH
The crystal structure of 14-3-3 epsilon in complex with the phosphorylated NELFE peptide
Deposited 2017-09-19
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
3–232(230 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;40% pentaerythritol propoxylate, 0.2M sodium thiocyanate, 0.1M HEPES, pH 7.0
|
Resolution 2.70 Å
R-free 0.241
|
|
7C8E
Crystal Structure of 14-3-3 epsilon with 9J10 peptide
Deposited 2020-05-30
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–232(232 aa)
Chain B
1–232(232 aa)
|
Not recorded
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289.15 K;28% PEG 400, 0.1M Hepes pH 7.5, 0.2M Calcium chloride
|
Resolution 3.16 Å
R-free 0.271
|
|
8DGM
14-3-3 epsilon bound to phosphorylated PEAK1 (pT1165) peptide
Deposited 2022-06-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–255(255 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;1.8 M ammonium sulfate, 0.1 M HEPES pH 7.5, 5% (v/v) MPD
|
Resolution 3.20 Å
R-free 0.266
|
|
8DGN
14-3-3 epsilon bound to phosphorylated PEAK2 (pS826) peptide
Deposited 2022-06-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–255(255 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;1.8 M ammonium sulfate, 0.1 M HEPES pH 7.5, 5% (v/v) MPD
|
Resolution 3.16 Å
R-free 0.295
|
|
8DGP
14-3-3 epsilon bound to phosphorylated PEAK3 (pS69) peptide
Deposited 2022-06-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–255(255 aa)
Chain B
1–255(255 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 2
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9.35;293 K;2M ammonium sulfate, 0.1 M sodium bicine pH 9.35, 5% (v/v) 2-methyl-2,4,-pentandiol (MPD)
|
Resolution 2.70 Å
R-free 0.233
|
|
8DGP
14-3-3 epsilon bound to phosphorylated PEAK3 (pS69) peptide
Deposited 2022-06-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–255(255 aa)
Chain D
1–255(255 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9.35;293 K;2M ammonium sulfate, 0.1 M sodium bicine pH 9.35, 5% (v/v) 2-methyl-2,4,-pentandiol (MPD)
|
Resolution 2.70 Å
R-free 0.233
|
|
8DP5
Structure of the PEAK3/14-3-3 complex
Deposited 2022-07-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
1–255(255 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;A final concentration of 0.1% of Octyl-beta-Glucoside (C14H28O6) was added to the sample before freezing.
cryo-EM vitrification conditions
Cryogen ETHANE;blot time = 7s
blot force = 4
|
Resolution 3.10 Å
|
|
8Q1S
Pathogenic mutations of human phosphorylation sites affect protein-protein interactions
Deposited 2023-08-01
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–255(255 aa)
Chain B
1–255(255 aa)
|
Not recorded
|
BR BROMIDE ION × 1
EDO 1,2-ETHANEDIOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;19% PEG 3350, 0.35 M NaBr, 0.1 M BisTris-Propane pH 6.5
|
Resolution 3.23 Å
R-free 0.279
|